Singapore markets closed

Agilent Technologies, Inc. (A)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
127.20-1.48 (-1.15%)
At close: 04:00PM EST
127.27 +0.07 (+0.06%)
After hours: 06:16PM EST

Agilent Technologies, Inc.

5301 Stevens Creek Boulevard
Santa Clara, CA 95051
United States
800 227 9770

IndustryDiagnostics & Research
Full-time employees18,000

Key executives

NameTitlePayExercisedYear born
Mr. Michael R. McMullenCEO, President & Director3.66M1.24M1961
Mr. Robert W. McMahonSenior VP & CFO1.54MN/A1969
Mr. Henrik Ancher-JensenSenior VP and President of Order Fulfillment & Supply Chain1.31MN/A1965
Mr. Samraat S. RahaSenior VP and President of Diagnostics & Genomics Group1.14MN/A1973
Mr. Rodney GonsalvesPrincipal Accounting Officer, VP & Corporate ControllerN/AN/A1966
Mr. John KohlSenior Vice President & Chief Information OfficerN/AN/AN/A
Mr. Michael TangSenior VP, General Counsel & Secretary871.02k290.31k1974
Mr. Dominique P. GrauSenior Vice President of Human Resources & Global Communications936.31kN/A1959
Ms. Allison BallmerSenior Vice President of Strategy & Corporate DevelopmentN/AN/AN/A
Ms. Yvonne MackieMD of UK & Ireland Operations and VP of Human Resources - EuropeN/AN/AN/A
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Corporate governance

Agilent Technologies, Inc.’s ISS governance QualityScore as of 1 December 2023 is 8. The pillar scores are Audit: 10; Board: 5; Shareholder rights: 9; Compensation: 5.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.